What is CJC-1295?

CJC-1295 is a modified analogue of growth hormone releasing hormone engineered for a much longer half life than the natural hormone or sermorelin. The 'DAC' version attaches a drug affinity complex that binds albumin in the blood, stretching its half life to roughly 6 to 8 days, versus minutes for the version without DAC. It is not FDA approved and is sold as a research chemical.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of growth hormone secretagogues. Sermorelin, tesamorelin, ipamorelin, CJC-1295, and the rest of the GHRH and ghrelin receptor family.